Category Archives: Myocardial Infarction

LOS ANGELES--(BUSINESS WIRE)--OTITOPIC A clinical-stage dry powder inhalation of aspirin pharmaceutical company pioneering the development of antithrombotic treatments for use at the time of suspected acute myocardial infarction (MI), today announced the successful conclusion based on PD results of a clinical trial for its lead drug: Dry Powder Inhalation of Aspirin (ASPRIHALE). ASPRIHALE is considered to be safe and well tolerable Continue reading →

A recent review and meta-analysis focus on the role of legumes in heart health. Taking data from multiple studies and earlier analyses, the authors conclude that legumes might benefit heart health but that the evidence is not overwhelming. It is a no-brainer that nutrition plays a pivotal role in health Continue reading →

Silk Road Medical announced the presentation of real-world data for the treatment of patients with carotid artery disease at risk for stroke at the VEITHsymposium in New York, USA (1923 November). In a headline presentation, Mahmoud Malas of the University of California, San Diego School of Medicine shared updated results for the ongoing TransCarotid Artery Revascularisation (TCAR) Surveillance Project contemporaneously comparing TCAR to the surgical standard of care, carotid endarterectomy (CEA). Our updated dataset now includes 6,526 matched patients Continue reading →

Treatment with evolocumab (Repatha; Amgen) within 1 year after a myocardial infarction (MI) was found to be beneficial in reducing the risk of subsequent MI, stroke, or cardiovascular death, according to new data from the FOURIER study. Findings were presented at the American Heart Association Scientific Sessions in Philadelphia, PA. In 2017, findings from the FOURIER trial led to the approval of evolocumab for the prevention of MI, stroke, and coronary revascularization in adults with established cardiovascular disease Continue reading →

BACKGROUND: Angiotensin-converting enzyme inhibitors (ACEIs) are the first choice for the treatment of acutemyocardial infarction(AMI), and angiotensin receptor blockers (ARBs) should be considered in patients intolerant to ACEIs. Continue reading →

A leading research firm, Zion Market Research added a latest industry report on "Global Myocardial Infarction Treatment Market" consisting of 110+ pages during the forecast period and Myocardial Infarction Treatment Market report offers a comprehensive research updates and information related to market growth, demand, opportunities in the global Myocardial Infarction Treatment Market. According to the report the Myocardial Infarction Treatment Market to witness steady growth increase by 2024 The Myocardial Infarction Treatment Market report provides in-depth analysis and insights into developments impacting businesses and enterprises on global and regional level. Continue reading →

A leading research firm, Zion Market Research added a latest industry report on "Global Myocardial Infarction Treatment Market" consisting of 110+ pages during the forecast period and Myocardial Infarction Treatment Market report offers a comprehensive research updates and information related to market growth, demand, opportunities in the global Myocardial Infarction Treatment Market. Continue reading →

A detailed study on the Myocardial Infarction Therapeutics Market published by Future Market Insights offers an in-depth understanding of the various elements that are expected to influence the growth of the Myocardial Infarction Therapeutics Market in the upcoming years. Continue reading →

The estimates displayed in the report have been obtained using proven research methods and assumptions. By doing so, the research report serves as a repository of analysis and information for every aspect of the market, including: but not limited to regional markets and applications. Key players cited in the report: Bayer Novartis Daiichi Sankyo Boehringer Ingelheim Astrazeneca Janssen Biotech Merck Sanofi Pfizer Click the link to get a Sample Copy of the Report: https://www.marketInsightsreports.com/reports/03191152586/global-myocardial-infarction-treatment-market-research-report-2019/inquiry?mode=86 Continue reading →

SELBYVILLE, Del. Continue reading →